fbpx
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

News

HERITAGE AND PHYEINMED SUBMIT EVIDENCE PACKAGE

HERITAGE CANNABIS HOLDINGS CORPORATION (CSE: CANN) (“Heritage” or “Company”) is pleased to announce that its subsidiary PhyeinMed Inc. (“PhyeinMed”), has submitted to Health Canada, the evidence of site and facility completion as noted in the letter ‘Confirmation of Readiness under the ACMPR’.
Read more

Leviathan Cannabis to acquire late-stage ACMPR applicant

Leviathan has agreed to acquire Woodstock Biomed Inc. Woodstock is a late stage applicant that has received its Confirmation of Readiness from Health Canada's Office of Medical Cannabis. Woodstock owns a prime, late stage ACMPR greenhouse production facility in Pelham, Ontario. This 29.5-acre property (the "Property") will serve as the Company's cornerstone for cannabis cultivation operations in Canada.
Read more
Get $50 in free trades.